Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
2.182
-0.058 (-2.60%)
Nov 17, 2026, 3:25 PM EST - Market open

Biodexa Pharmaceuticals Statistics

Total Valuation

BDRX has a market cap or net worth of $280,651. The enterprise value is -$4.00 million.

Market Cap280,651
Enterprise Value -4.00M

Important Dates

The last earnings date was Friday, September 11, 2026, after market close.

Earnings Date Sep 11, 2026
Ex-Dividend Date n/a

Share Statistics

BDRX has 128,633 shares outstanding.

Current Share Class n/a
Shares Outstanding 128,633
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 2.15%
Owned by Institutions (%) 8.36%
Float 115,517

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.02
P/TBV Ratio 0.06
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.41, with zero debt.

Current Ratio 2.41
Quick Ratio 2.41
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -58.15

Financial Efficiency

Return on equity (ROE) is -42.00% and return on invested capital (ROIC) is -138.48%.

Return on Equity (ROE) -42.00%
Return on Assets (ROA) -40.11%
Return on Invested Capital (ROIC) -138.48%
Return on Capital Employed (ROCE) -88.89%
Weighted Average Cost of Capital (WACC) 11.23%
Revenue Per Employee n/a
Profits Per Employee -$533,127
Employee Count11
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, BDRX has paid $137,986 in taxes.

Income Tax 137,986
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.98% in the last 52 weeks. The beta is 1.27, so BDRX's price volatility has been higher than the market average.

Beta (5Y) 1.27
52-Week Price Change -98.98%
50-Day Moving Average 4.38
200-Day Moving Average 20.55
Relative Strength Index (RSI) 31.02
Average Volume (20 Days) 27,309

Short Selling Information

The latest short interest is 5,752, so 1.10% of the outstanding shares have been sold short.

Short Interest 5,752
Short Previous Month 919,936
Short % of Shares Out 1.10%
Short % of Float n/a
Short Ratio (days to cover) 0.01

Income Statement

Revenue n/a
Gross Profit -6.92M
Operating Income -11.73M
Pretax Income -5.73M
Net Income -5.86M
EBITDA -11.74M
EBIT -11.73M
Earnings Per Share (EPS) -$102.50
Full Income Statement

Balance Sheet

The company has $4.29 million in cash and no debt, with a net cash position of $4.29 million or $33.32 per share.

Cash & Cash Equivalents 4.29M
Total Debt n/a
Net Cash 4.29M
Net Cash Per Share $33.32
Equity (Book Value) 12.75M
Book Value Per Share 136.76
Working Capital 5.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.10 million and capital expenditures -$9,235, giving a free cash flow of -$9.11 million.

Operating Cash Flow -9.10M
Capital Expenditures -9,235
Depreciation & Amortization -10,554
Net Borrowing -695,234
Free Cash Flow -9.11M
FCF Per Share -$70.82
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BDRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -4,698.18%
FCF Yield -3,105.97%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on October 26, 2026. It was a reverse split with a ratio of 1:8.

Last Split Date Oct 26, 2026
Split Type Reverse
Split Ratio 1:8

Scores

Altman Z-Score n/a
Piotroski F-Score n/a